entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 17:56:59 - browse：98394

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： UCLA team creates talking throat patch for voice disorders

focus

WSS

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Readout Newsletter: CAR

Deliver public health messages at the right time

Steward Health Care Massachusetts hospitals face fiscal disaster

Novel spinal cord stimulator treats paralysis without surgery

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Medicare details structure of new drug price negotiation program

Boston's new lab space is opening empty

Medicare proposal to cover medical devices draws a mixed reaction

Why scientists need input from humanists on sensitive research

Virginia high school admissions case could be legal follow

PBM executives asked to testify by House panel

Continuity nursing helped my family in our darkest PICU moments

Brain MRIs reveal impact of 'toxic stress' on Black children

Apple is now the first public company to be valued at $3 trillion

John Green on his newest strategy for fighting tuberculosis

hotspot

As billionaires fund anti

How a small hospital in rural Puerto Rico survived Hurricane Maria

Change Healthcare outage fallout shows need for new oversight

UCLA team creates talking throat patch for voice disorders

HHS secretary Becerra pressed on Change HealthCare cyberattack

Change Healthcare outage fallout shows need for new oversight

leisure time

knowledge

focus

Wikipedia